Bendamustine Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

43 Suppliers, 24 USDMF, 7 JDMF, 9 EU WC, 7 KDMF, 12 NDC API, 26 Listed Suppliers

DEVELOPMENTS

23 Drug(s) in Development

23 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

7 Suppliers

7 Suppliers

DOSSIERs // Finished Dosage Forms

122 Dossiers, 39 FDA Orange Book, 24 Europe, 12 Canada, 16 Australia, 4 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION;INTRAVENOUS - 100MG/4ML (25MG/ML), SOLUTION;IV (INFUSION) - 100MG/4ML (25MG/ML), SOLUTION;INTRAVENOUS - 100MG/4ML (25MG/ML)

RELATED EXCIPIENT COMPANIES

Suppliers, 12 SPI Pharma, 3 Roquette, 2 BASF, 2 Microlex e.U, 2 Kerry, 2 Nanjing Well Pharmaceutical, 2 Gangwal Healthcare, 2 Gangwal Chemicals, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Finar, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Clariant, 1 Rochem International Inc, 1 Ingredion Pharma Solutions, 1 Sigachi Industries, 1 Pfanstiehl, 1 Actylis, 1 DKSH

EXCIPIENTS BY APPLICATIONS

19 Fillers, Diluents & Binders, 10 Chewable & Orodispersible Aids, 10 Direct Compression, 9 Taste Masking, 6 Parenteral, 4 Co-Processed Excipients, 4 Topical, 3 Thickeners and Stabilizers, 3 Disintegrants & Superdisintegrants, 3 Film Formers & Plasticizers, 3 Granulation, 1 Surfactant & Foaming Agents, 1 Coating Systems & Additives, 1 API Stability Enhancers, 1 Solubilizers, 1 Rheology Modifiers

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions, 20 Finished Drug Prices

MARKET PLACE

4 APIs, 8 DOSSIERS // FDF

PATENTS

91 US Patents

91 US Patents

ANALYTICAL SOLUTION(s)

5 USP Standards, 14 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 85 News

Annual Sales of Bendamustine Hydrochloride reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Bendamustine Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

43 Suppliers

24 USDMF

7 JDMF

9 EU WC

7 KDMF

12 NDC API

26 Listed Suppliers

DEVELOPMENTS

23 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

7 Suppliers

DOSSIERs // Finished Dosage Forms

122 Dossiers

39 FDA Orange Book

24 Europe

12 Canada

16 Australia

4 South Africa

27 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION;INTRAVENOUS - 100MG/4ML (25MG/ML)

SOLUTION;IV (INFUSION) - 100MG/4ML (25MG/ML)

SOLUTION;INTRAVENOUS - 100MG/4ML (25MG/ML)

RELATED EXCIPIENT COMPANIES

Suppliers

12 SPI Pharma

3 Roquette

2 BASF

2 Microlex e.U

2 Kerry

2 Nanjing Well Pharmaceutical

2 Gangwal Healthcare

2 Gangwal Chemicals

1 Shijiazhuang Huaxu Pharmaceutical

1 Finar

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Clariant

1 Rochem International Inc

1 Ingredion Pharma Solutions

1 Sigachi Industries

1 Pfanstiehl

1 Actylis

1 DKSH

EXCIPIENTS BY APPLICATIONS

19 Fillers, Diluents & Binders

10 Chewable & Orodispersible Aids

10 Direct Compression

9 Taste Masking

6 Parenteral

4 Co-Processed Excipients

4 Topical

3 Thickeners and Stabilizers

3 Disintegrants & Superdisintegrants

3 Film Formers & Plasticizers

3 Granulation

1 Surfactant & Foaming Agents

1 Coating Systems & Additives

1 API Stability Enhancers

1 Solubilizers

1 Rheology Modifiers

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions

20 Finished Drug Prices

MARKET PLACE

4 APIs

8 DOSSIERS // FDF

PATENTS

91 US Patents

ANALYTICAL SOLUTION(s)

5 USP Standards